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The effect of metal complexation on the antimicrobial activity of
1,4-naphthoquinones was investigated. Nickel-, chromium-, iron-,
copper-, and cobalt-containing metal chelates of 5-amino-8-
hydroxy-1,4-naphtoquinone (2) and its acyl-derivatives (3-8) were
synthesized and characterized, and their antimicrobial activity was
evaluated. Data from infrared spectroscopy indicate that
naphthoquinones coordinate through oxygen and nitrogen atoms
for 2, and through oxygen atoms when ligands were acyl derivatives
3-8. Susceptibility tests for antimicrobial activity showed that 2
and its acyl derivatives were effective on inhibiting the growth of
pathogenic bacteria such as Staphylococcus aureus, Streptococcus
uberis and Bacillus cereus, but not Gram-negative bacteria. The
metal complexation often caused decrease of biological activity.
Nickel complex of 2 was the most effective against Gram-positive
bacteria, showing MIC values ranging from 375 to 1400 mg/ml.
Metal chelates may be useful tools for the understanding of the
antimicrobial mechanism of 1,4-naphthoquinones on these bacteria.
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INTRODUCTION
Naphthoquinones are largely found in plants,
microorganisms, and some animals. These compounds
have been widely used in diverse cultures such as
colorants for cosmetics, fabrics, foods, and for medicinal
purposes, including antitumor, anti-inflammatory, and
antimicrobial agents (Thomson, 1971; Masuda et al.,
1987; Papageorgiou et al., 1999). Naphthoquinones are
also described as precursors of more complex structures
(Couladouros, Plyta, Papageorgiou, 1996). The 5,8-
dihydroxy-1,4-naphthoquinone and the 5-amino-8-
hydroxy-1,4-naphthoquinone are known as precursors of
the anthracyclinone system and aglycones of the
anthracyclines (Fariña et al., 1985).
The investigation on new antimicrobial agents is
important due to the resistance acquired by several
pathogenic microorganisms. The prevalence of strains of
Staphylococcus aureus  resistant to conventional
antibiotics has increased to high levels in some hospitals
(Emori, Gaynes, 1993). Increased resistance among
strains of streptococci and enterococci are also described
(Lipsitch, 2001).
The biological activity of several well-known and
widely used anthracycline antibiotics such as daunomycin
and doxorubicin is thought to be associated to the
hydroxyquinone structure (Young, Ozols, Myers, 1981).
Moreover, equivalent active sites are also present in the
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tetracycline antibiotics as well as in myxopyronin (Smilack,
Wilson, Cockerill, 1990; Chopra, Hawkey, Hinton, 1991).
The antibacterial effect is also related to naphthoquinones
from vegetal origin (Didry, Pinkas, Dubreil, 1986; Machado
et al., 2003), synthetic naphthoquinones (Oliveira et al.,
2001; Riffel et al., 2002) and isoxazolyl-naphthoquinones
(Bogdanov et al., 1995). In addition, the fungitoxic effect of
1,4-naphtoquinones (Gershon, Shanks, 1975; Sasaki, Abe,
Yoshizaki, 2002) and the antiviral activity of some
hydroxyquinones (Meruelo, Javie, Lavie, 1988;
Brinkworth, Fairlie, 1995) have been described.
The effect of metal complexation on some
antimicrobial agents has been mentioned in the literature.
Tetracyclines often lose their antimicrobial activity when
coordinated with metals (Chopra, Hawkey, Hinton, 1991).
Some cations such as magnesium and aluminium are
complexed by fluoroquinolones, resulting in decrease in
oral bioavailability, and may cause therapeutic failure
(Lecomte et al., 1994; Wallis et al., 1996). However,
increased activity has been described for some
hydroxyquinone metal-chelates (Christianopoulou,
Ecateriniadou, Sarris, 1986) and a copper(II) complex of
cephalexin (Iqbal et al., 1999).
In this paper we report on the screening of in vitro
activity of naphthoquinones derived from 5-amino-8-
hydroxy-1,4-naphthoquinone and their metal chelates as
part of our interest on the synthesis and characterization of
the naphtoquinones derivatives and their transition metal
complexes.
MATERIALS AND METHODS
Naphthoquinones and metal complexes
All organic compounds used in this work were
synthesized and characterized in this laboratory and will
be assigned as: 5-amino-8-hydroxy-1,4-naphthoquinone
(2), and a series of derivatives 5-acetylamino-8-hydroxy-
1,4-naphthoquinone (3), 5-octanoylamino-8-hydroxy-1,4-
naphthoquinone (4), 5-decanoylamino-8-hydroxy-1,4-
naphthoquinone (5), 5-dodecanoylamino-8-hydroxy-1,4-
naphthoquinone (6), 5-tetradecanoylamino-8-hydroxy-
1,4-naphthoquinone (7) and 5-hexadecanoylamino-8-
hydroxy-1,4-naphthoquinone (8). Their complexes will be
referred as M(2) when the chelate is formed by metal (M)
and compound 5-amino-8-hydroxy-1,4-naphthoquinone
(2); M(3) for chelates 5-acetylamino-8-hydroxy-1,4-
naphthoquinone (3) and there forth. Their structures are
shown in Figure 1.
The synthesis of 5-amino-8-hydroxy-1,4-
naphtoquinone (2) have been described in the literature
(Fariña et al. , 1995), while the synthesis of new
derivatives (3-8) and their metal chelates have been
subject of recent studies of this group (Martinelli et al.,
1999, 2000). The structures of the synthesized compounds
were confirmed by 1H-NMR, 13C-NMR, UV-Visible, and
elemental analysis. Infrared spectra (4000-200 cm-1) were
recorded on a Mattson GL3020 instrument using KBr
discs.
Microorganisms
The strains tested for antibacterial activity were
clinical isolates obtained at the Faculdade de Medicina
Veterinária, UFRGS. Screening tests were carried out on
the following bacteria: Staphylococcus aureus,
Staphylococcus epidermidis, Staphylococcus intermedius,
Enterococcus faecalis, Streptococcus uberis, Escherichia
coli, Pseudomonas fluorescens, Bacillus cereus,
Salmonella Typhimurium. Strains from collection were S.
aureus ATCC 25923 and E. coli ATCC 25922. Stock
cultures were kept frozen at –21 °C in nutrient broth
(Difco) containing 20% (v/v) glycerol. The organisms
were propagated and maintained on nutrient agar dishes at
4 °C during the susceptibility experiments. Strains of S.
uberis were submitted to susceptibility tests after isolation
on 5% blood sheep agar.
Susceptibility testing
The susceptibility tests were performed following the
NCCLS recommendations (NCCLS, 2001). Screening tests
regarding the inhibition zone were carried out by the filter
paper disk method. Bacterial suspension was prepared from
colonies grown overnight on an agar plate, and inoculated
into Mueller-Hinton broth (Merck) to give a 0.5 McFarland
turbidity standard solution. A sterile swab was immersed in
FIGURE 1 - Chemical structures of the naphthoquinones
tested. The metal ion coordinates through site B for ligand
(2) and site A for the acyl-derivatives (3 to 8).
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the bacterial suspension and used to inoculate Mueller-
Hinton agar plates. The disks were applied to the surface of
inoculated plates using a sterile forceps. The compounds
were diluted in phosphate buffered saline solution from a 10
mg/ml stock dimethylsulfoxide (DMSO) solution and then
applied on disks (50 mg/disk). The inhibition zone was
measured around each disk after 24 h at 37 °C. Strains of E.
faecalis and S. uberis were tested on Mueller-Hinton agar
plates supplemented with 5% sheep blood. Controls with
DMSO were adequately done.
To access the Minimum Inhibitory Concentration
(MIC) – defined as the drug concentration at which no
growth was visible – 96-well sterile microplates (Corning)
were filled with 0.1 ml of serial twofold dilutions (2000 to
4 µg/ml) of the different naphthoquinones. The
compounds were diluted in Mueller-Hinton broth from a
10 mg/ml stock DMSO solution. A standardized number
of bacteria (0.1 ml of a 106 CFU/ml suspension in Mueller-
Hinton broth) were inoculated into each well. A growth
well (broth plus inoculum) and a sterility control well
(broth only) were included in each panel. Microplates
were incubated at 37 °C for 24 h, and then MIC was
determined as the last dilution where no increase in visu-
al turbidity was observed.
RESULTS
The naphthoquinone compounds and their chelates
were synthesized as described elsewhere (Martinelli et al.,
1999, 2000). All the chelates were made of bivalent me-
tal, except Cr(III). They are neutral complexes and were
isolated as fine powders. They are quite insoluble in
common organic solvents despite the lipophylic chain on
compounds 4 to 8 and are thermally more stable than the
free organic ligands, as should be expected. The most
important changes in the IR spectrum of ligands 2 and 3
and their nickel chelates, Ni(2) and Ni(3), can be seen in
Table I.
Compounds 2 to 8 and their metal chelates were
initially tested against Staphylococcus aureus ATCC 25923
and Escherichia coli ATCC 25922. Antimicrobial activity
of 2-8 was observed on S. aureus but not on E. coli (not
shown). The acyl-derivatives presented lower inhibition
zones than the starting compound 2 (Table 2). Metal
chelates showed either decreased antibacterial activity or
lack of inhibitory effect. The nickel complexes of 2 and 3
and the cobalt complex of 2 were the most active (Table II).
The biological effect of 2, and their metal-chelates
on bacterial growth is shown in Table III. The ligand 2 was
capable of inhibiting the growth of S. aureus ,  S.
intermedius, S. epidermidis, B. cereus, S. uberis and E.
faecalis. Nickel, cobalt and iron complexes of 2 showed a
decreased inhibitory effect when compared with the ligand
alone. Lack of inhibitory effect was observed for copper
and chromium chelates. The activity of these compounds
was also tested on Gram-negative microorganisms, such
as Escherichia coli, Pseudomonas fluorescens, and
TABLE I - Most relevant infrared frequencies of some characteristic bands of 5-amino-8-hydroxy-1,4-naphthoquinone
(2),5-acetylamino-8-hydroxy-1,4-naphthoquinone (3) and their Ni-chelates Ni(2) and Ni(3), respectively
Band ν(N-H)2) ν(N-H) ν(O-H) ν(NHC=O) ν(C=O)1 ν(C=O)4 ν(C-OH) ν(C-OM) νass(M-O) νsim(M-O)
(2) 3346w 3154w 1606vs 1242s
3259m
Ni(2) 3275m 1640m 1580vs 1240br,vs 459w 268w
(3) 3208w 3081w 1697s 1623vs 1269vs 456w 256w
1220vs
Ni(3) Broad 1669m 1566vs 1590vs 111280s
1250sh,s
TABLE II - Effect of 1,4-naphthoquinones and metal
chelates on growth of Staphylococcus aureus*
Metal Complex
Compound None Ni Co Fe Cu Cr
2 21 16 14 12 - -
3 16 12 10 - - -
4 12 - - - - -
5 10 9 - - 9(v) -
6 12 - 9(v) - - -
7 10 - - - - -
8 9 - - - - -
* Inhibition zone in mm. Results are the means of five
independent determinations for each isolate. (-) no
inhibition was observed. (v) inhibition was not observed
against all isolates.
A. Brandelli, D. Bizani, M. Martinelli, V. Stefani, A. E. Gerbase250
Salmonella Thyphimurium. None of the compounds were
able to inhibit the growth of those Gram-negative bacteria
(Table III).
The effect of nickel and cobalt complexation of 2 on
MIC values was determined against Gram-positive
bacteria (Table IV). Compound 2 presented MIC values in
the 30 to 125 mg/ml range, whereas the Ni(2) complex
resulted in MIC values ranging from 375 to 1400 mg/ml.
Nickel complexation of 3 or 5 caused increase of MIC to
values higher than 2000 mg/ml (not shown).
DISCUSSION
In the previous work we showed that naphtho-
quinone ligands have two potential sites to coordinate a
metal ion (Martinelli et al., 1999, 2000). Spectroscopic
data allowed us to assign that the metal ion coordinates
through site B for ligand 2, while site A is preferred by the
metal in the acyl-derivatives 3 to 8 (Figure 1).
Metal chelates of compound 2 and its derivatives 3
to 8 have been synthesized and were tested against Gram-
positive and Gram-negative bacteria. In Tables 2 and 3 it
is possible to observe that all the ligands showed
antibacterial activity. Compound 2 showed higher activity
compared with its derivatives 3 to 8. All compounds
possess the free naphthazarin site (site A, Figure 1), which
has been associated with antibacterial properties
(Papageorgiou, et al.1999).
Studies on antimicrobial activity of 1,4-
naphtoquinones demonstrated that those with electron-
releasing or weak electron-withdrawing groups at position
2 or 3 may enhance their antimicrobial activity (Ambrogi
et al., 1970; Gershon, Shanks, 1975). An explanation for
this behavior is related to the electronic effect of the
groups directly bonded at the naphthoquinone ring. This
effect is attributed to the enhancement of the hydrogen
bonding, allowing stronger binding at its site of action.
Nevertheless, in our case, the acyl compounds 3 to 8
showed a decrease in activity, although they present the
site A free. Such behavior could be explained considering
that the group R is not directly bound to the
naphthoquinone ring and does not cause a positive
electronic effect. Furthermore, the decrease in activity
observed for the acyl derivatives may be related to the
presence of the lipophylic group, since excess of
hydrophobicity causes loss of activity (Gershon, Shanks,
1975).
TABLE III - Susceptibility testing of 5-amino-8-hydroxy-1,4-naphthoquinone metal-chelates*
Microorganism Compound
(No. of isolates) 2 Ni(2) Co(2) Fe(2) Cu(2) Cr(2)
S. aureus ATCC 25923 23 18 14 14 - -
S. aureus (10) 21 16 14 12 - -
S. intermedius (5) 26 18 14 15 - -
S. epidermidis (10) 21 16 15 - - -
B. cereus (4) 18 11 - - - -
S. uberis (3) 19 17 14 - - -
E. faecalis (5) 20 15 12 - - -
E. coli ATCC 25922 - - - - - -
E. coli (10) - - - - - -
P. fluorescens (5) - - - - - -
S. Thyphimurium (7) - - - - - -
* Inhibition zone in mm. Results are the means of five independent determinations for each isolate. (-) no inhibition was
observed.
TABLE IV - Minimal inhibitory concentrations of
compound 2 and its nickel and cobalt complexes against
Gram-positive bacteria
Microorganism MIC (µg/mL)
(No. of isolates) (2) Ni(2) Co(2)
S. aureus ATCC 25923 30 500 500
S. aureus (10) 32 475 1100
S. intermedius (5) 34 600 800
S. epidermidis (10) 50 455 1050
B. cereus (4) 125 1400 -
S. uberis (3) 52 375 >2000
E. faecalis (5) 81 700 >2000
Results are the means of five independent determinations
for each isolate. (-) no inhibition was observed.
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Antimicrobial activity of metal complexes of
naphthoquinones has been described. Some metal chelates
of juglone often maintain their antibacterial effect (Joshi,
1986). (II) and Ni(II) complexes of 5-hydroxy-1,4-
naphthoquinone result in higher antibacterial effect
against Bacillus spp. and S. aureus (Christianopoulou,
Ecateriniadou, Sarris, 1986). In addition, the Ni(II)
complex of vitamin K3-thiosemicarbazole has been
recently reported to increase the activity against Gram-
positive bacteria (Li et al., 2000). Therefore, the effect of
metal complexation on antimicrobial activity was a matter
of our interest since the chelation of 2 occurred in site B,
leaving the naphthazarin site A free.
The data obtained for the metal chelates showed
lower activity than their respective ligands, and total loss
of activity was observed in some cases. Considering that
the naphthazarin site A is the active one, its blocking by
complexation may be related with the decrease or loss of
activity. In fact, site A remains free after coordination in
the case of ligand 2 ,  but it is involved in metal
complexation in 3 to 8. Assuming that the antibacterial
mechanism is interfering in the electron transport chain,
this free site should be required to participate in a redox
reaction. This idea may be supported by electrochemical
studies on 3 and Ni(3), in which the reduction potential
becomes more negative with complexation (Piatnicki et
al., 1996), i.e., more energy is required for the reduction
process. In addition, the presence of an imino group
instead of a keto group in position 1 or 4 results in loss of
antimicrobial activity (Riffel et al., 2002). This may
indicate that both free C=O groups are required for full
activity.
The set of data of compound 2 and its metal chelates
showed the highest activity compared to the other
chelates. The Ni(2) complex was found to be slightly less
active than the ligand itself, nevertheless it followed the
behavior of 2 being the most active against all Gram-
positive bacteria tested. This was an unexpected result
since the naphthazarin site is kept uncoordinated in the
chelates unless the electrochemical behavior of the ligand
has been modified by the metal ion.
As the ligands and some complexes were active
against S. aureus, which is a very relevant pathogen, me-
tal chelates may be useful tools for the understanding of
the antimicrobial mechanism of 1,4-naphthoquinones on
this bacterium.
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RESUMO
Atividade antimicrobiana de 1,4-naftoquinonas por
complexação com metais
O efeito da complexação com metais sobre a atividade
antimicrobiana de 1,4-naftoquinonas foi investigado.
Complexos contendo níquel, cromo, ferro, cobre e cobalto
da 5-amino-8-hidroxi-1,4-naftoquinona (2) e seus acil-
derivados (3-8) foram sintetizados e caracterizados e sua
atividade antimicrobiana foi avaliada. Dados de
espectroscopia de infravermelho indicaram que as
naftoquinonas coordenam os metais através dos átomos
de oxigênio e nitrogênio para 2 e através de átomos de
oxigênio, quando os ligantes são os acil-derivados 3-8.
Testes de sensibilidade antimicrobiana demonstraram que
2 e seus derivados foram efetivos na inibição do cresci-
mento de bactérias patogênicas como Staphylococcus
aureus, Streptococcus uberis e Bacillus cereus, mas não
apresentaram efeito contra bactérias Gram-negativas. A
complexação de metais geralmente causou diminuição da
atividade biológica. O complexo de níquel de 2 foi o mais
eficaz contra bactérias Gram-positivas, apresentando
valores de MIC de, 375 a 1400 μg/mL. Os complexos
metálicos podem ser ferramentas úteis para o estudo do
mecanismo antimicrobiano de 1,4-naftoquinonas nestas
bactérias.
UNITERMOS: Antimicrobiano. 5-Amino-8-hidroxi-1,4-
naftoquinona. Complexo metálico. Hidroxiquinona.
Estafilococos
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